Gene Therapy Market Size is Expected to Reach USD 29.24 Billion by 2033, Growing at a CAGR of 18.60%: Straits Research
20. Januar 2025 10:05 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Gene therapy prevents the progression of an illness by altering the expression of mutated genes or the biological characteristics of living...
Cell Therapy Technologies Market Forecasts 2024-2029: Advancements in Gene Editing Technologies, Development of Automated Cell Processing Systems and Regulatory Support for Fast-tracking Therapies
16. Januar 2025 04:43 ET
|
Research and Markets
Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "Cell Therapy Technologies Market by Product (Media, Sera & Reagents, Vessels, Single-Use Equipment), Process (Cell Processing, Preservation,...
Biotherapeutics Market Insights 2025, Analysis and Forecast to 2030: Insulin Demand Soars Amid Diabetes Epidemic, Sees $40 Billion Opportunity
13. Januar 2025 06:40 ET
|
Research and Markets
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Biotherapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type" report...
Ori Biotech Expands Team to Advance IRO Commercialization and Industry Partnerships
09. Januar 2025 08:30 ET
|
Oribiotech Ltd
Ori Biotech announces the appointment of two new members to its senior team and new members to its Strategic Advisory Board (SAB).
NurExone Biologic Secures Master Cell Bank
08. Januar 2025 16:12 ET
|
NurExone Biologic Inc
NurExone Biologic Secures Master Cell Bank - a Key Milestone for Therapeutic Exosome Production
Regenerative Medicine Market Size to Hit USD 235.98 Billion by 2032, Driven by Advancements in Cell Therapy and Stem Cells – SNS Insider
08. Januar 2025 08:00 ET
|
SNS Insider pvt ltd
Pune, Jan. 08, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Regenerative Medicine Market was estimated at USD 32.50 billion in 2023 and is projected to reach USD 235.98 billion in 2032,...
Ori Biotech Announces First Customer Deliveries of IRO to Leading CDMOs and Commercial CGT Manufacturers
07. Januar 2025 08:30 ET
|
Ori Biotech Ltd
Ori Biotech announces the first customer deliveries of the IRO® platform, designed to help address the current challenges in CGT manufacturing.
CytoMed Therapeutics signs Business & Research Collaboration Agreement with India’s SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf Gamma Delta T Cells for treatment of solid cancers in a proposed Phase 2 clinical trial in India
06. Januar 2025 07:00 ET
|
CYTOMED THERAPEUTICS LIMITED
SINGAPORE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing...
CAR-T Cell Therapy Market Research 2024-2025: Navigating the CAR-T Landscape, Major Players, Recent Approvals, and Pioneering Therapies
03. Januar 2025 04:09 ET
|
Research and Markets
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "CAR-T Cell Therapy Market - Market Size, Forecasts, Trials, and Trends, 2025" report has been added to ResearchAndMarkets.com's offering. This...
Cell and Gene Therapies Current and Future Landscape 2025-2030
02. Januar 2025 05:05 ET
|
Research and Markets
Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapies - Current and Future Landscape" report has been added to ResearchAndMarkets.com's offering.The global CGT market is expected...